Masimo (MASI) Stock Highlights

171.02 | +1.61%

2024-12-27 01:29:16

Masimo is an Irvine, California-based medical device business that focuses on noninvasive patient monitoring. It began by developing superior signal processing algorithms to measure blood oxygenation levels through pulse oximetry and has expanded this expertise into a wide range of measurements and applications. The company generates revenue globally, with the United States the largest market (67% of 2020 sales), followed by Europe, the Middle East, and Africa (21%), Asia and Australia (9%), and North and South America excluding the U.S. (3%).

Statistics

Range Today

166.7 172.1

Volume Today 349.2K

Range 1 Year

101.61 180.97

Volume 1 Year 167.65M

Range 3 Year

75.22 299.78

Volume 3 Year 552.19M

Range 10 Year

25.12 305.21

Volume 10 Year 1.3B

Highlights

Market Capitalization 8.7B (mid)

Floating Shares 44.49M

Current Price 171.02

Price To Earnings 112.23

Price To Revenue 4.57

Price To Book 5.94

Earnings Per Share 1.45

Payout Ratio 0%

Performance

Latest +1.61%

1 Month -3.76%

3 Months +27.63%

6 Months +30.61%

1 Year +43.71%

3 Years -42.18%

5 Years +7.28%

10 Years +539.57%

Benchmarks

Market Capitalization

13 / 44

Gross Profits

14 / 40

Total Revenue

15 / 43

Total Rank

11 / 44

Free Cashflow

19 / 44

Performance 5 years

16 / 44

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.